Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane-based regimens

MeSH terms

• Aged
• Antibodies, Monoclonal, Humanized* / administration & dosage
• Antibodies, Monoclonal, Humanized* / therapeutic use
• Antineoplastic Agents, Immunological / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Female
• Humans
• Male
• Mutation*
• Paget Disease, Extramammary* / diagnosis
• Paget Disease, Extramammary* / drug therapy
• Paget Disease, Extramammary* / genetics
• Paget Disease, Extramammary* / pathology
• Skin Neoplasms / drug therapy
• Skin Neoplasms / genetics
• Skin Neoplasms / pathology
• Taxoids* / administration & dosage
• Taxoids* / therapeutic use
• Treatment Failure